Samsung Life Insurance Launches Revised ‘The First Health Insurance S

암·순환계 통합치료비 확대…최신 항암치료 보장 강화

Samsung Life InsuranceOn the 10th, a revised version of ‘Samsung The First Health Insurance S’ was launched, with enhanced coverage to prepare for the entire treatment process for cancer and major circulatory diseases.

This revised product is characterized by expanded integrated coverage based on the actual treatment journey from examination to treatment and rehabilitation. This product, launched last year, has established itself as Samsung Life Insurance’s representative comprehensive health insurance with a family combination discount that provides a discount on insurance premiums when the family subscribes together, and an accident-free customer contract conversion system that allows lower insurance premiums when health conditions improve.

Through this revision, Samsung Life Insurance has integrated the core coverage required for the treatment of cancer and major circulatory diseases into one structure. We have established a new ‘Cancer Integrated Treatment (General Hospital and above) Special Contract AT’, which covers treatment costs incurred at general hospitals or higher medical institutions within the annual subscription amount, allowing extensive preparation for the entire treatment process, including imaging, detailed examination, surgery, anticancer drug treatment, radiation therapy, pain relief treatment, and rehabilitation treatment.

We have also strengthened coverage for non-benefit areas where the full amount is incurred out-of-pocket. Through the ‘Full out-of-pocket (including non-coverage) cancer integrated treatment (general hospital or higher) special contract AT’, the scope of coverage has been expanded to include high-cost non-coverage treatments such as robotic surgery, some targeted/immuno anti-cancer treatments, and proton radiation therapy.

Coverage for circulatory diseases has also been strengthened. The burden of treatment costs can be lowered through the ‘Special Contract AT for Integrated Treatment of Major Circulatory Diseases (General Hospital and Above)’, which covers surgery, thrombolytic treatment, paid thrombectomy, intensive care unit treatment, and rehabilitation treatment for cerebrovascular diseases and heart diseases.

Recently, in the field of cancer treatment, the introduction of new medical technologies such as targeted treatment that precisely attacks cancer cells and radioligand treatment using radioisotopes is expanding. Accordingly, Samsung Life Insurance strengthened preparations for high-cost non-covered anticancer treatment by establishing a new ‘targeted anticancer drug/specific targeted radiation treatment special contract’.

Samsung The First Health Insurance S can be subscribed to from the age of 15 to up to 75 years of age, and the payment period can be selected from 10 years, 15 years, 20 years, and 30 years.

An official from Samsung Life Insurance said, “The biggest feature of this revised product is that it integrates coverage based on the actual customer’s treatment journey,” and added, “We will continue to expand the health coverage that customers can experience in line with the changing medical environment.”

Reporter Hong Seung-hae hae810@viva100.com